Mice overexpressing human lecithin: Cholesterol acyltransferase are not protected against diet-induced atherosclerosis

APMIS

Volumn 105, Issue 11, 1997, Pages 861-868

  Mehlum, Anja ^a   Muri, Merete ^a   Hagve, Tor Arne ^b   Solberg, Lars Åge ^c   Prydz, Hans ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Oslo City Hosp   (Norway)

Author keywords

Atherosclerosis; LCAT; Lipoprotein; Transgenic mice; Triglycerides

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; LIPOPROTEIN METABOLISM; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030812633     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05095.x     Document Type: Article

References (37)

1. Agellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X. C., Shelanski, S. A., Breslow, J. L. & Tall, A. R.: Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266: 10796-10801, 1991.
2. Bachorik, P. S. & Albers, J. J.: Precipitation methods for quantification of lipoproteins. Methods Enzymol. 729: 78-85, 1986.
3. Barter, P. J. & Rye, K.-A.: Molecular mechanisms of reverse cholesterol transport. Curr. Opin. Lipidol. 7: 82-87, 1996.
4. Brousseau, M. E., Santamarina-Fojo, S., Zech, L. A., Bérard, A. M., Vaisman, B. L., Meyn, S. M., Powell, D., Brewer, H. B., Jr. & Hoeg, J. M.: Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. J. Clin. Invest. 97: 1844-1851, 1996.
5. Chen, C.-H. & Albers, J. J.: Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J. Lipid Res. 25: 680-691, 1982.
6. Clay, M. A., Hopkins, G. J., Ehnholm, C. P. & Barter, P. J.: The rabbit as an animal model of hepatic lipase deficiency. Biochim. Biophys. Acta 1002: 173-181, 1989.
7. Dinchak, J., Hart, J., Gonzalez, G., Karmann, G., Schmidt, D. & Wirak, D. O.: Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein. Biochim. Biophys. Acta 1255: 301-310, 1995.
8. Dolphin, P. J.: Lipolytic enzymes and the role of apolipoproteins in the regulation of their activity. In: Rosseneu, M. (Ed.): Structure and function of apolipoproteins. CRC Press, Inc., USA 1992, pp. 324-332.
9. Duverger, N., Kruth, H., Emmanuel, F., Caillaud, J.-M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L. M. & Denefle, P.: Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94: 713-717, 1996.
10. Fielding, C. J. & Fielding, P. E.: Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228, 1995.
11. Fossati, P. & Prencipe, L.: Serum triglycerides determined colorimetrically with one enzyme that produces hydrogen peroxide. Clin. Chem. 28: 2077-2080, 1982.
12. Francone, O. L., Gong, E. L., Ng, D. S., Fielding, C. J. & Rubin, E. M.: Expression of human lecithin-cholesterol acyltransferase in transgenic mice. J. Clin. Invest. 96: 1440-1448, 1995.
13. Glomset, J. A., Assmann, G., Gjone, E. & Norum, K. R.: Lecithin: cholesterol acyltransferase deficiency and fish eye disease. In: Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D. (Eds.): The metabolic and molecular bases of inherited disease. McGraw-Hill, Inc., USA 1995, pp. 1933-1951.
14. Hoeg, J. M., Santamarina-Fojo, S., Bérard, A. M., Cornhill, J. F., Herderick, E. E., Feldman, S. H., Haudenschild, C. C., Vaisman, B. L., Hoyt, R. F., Jr., Demosky, S. J., Kauffman, R. D., Hazel, C. M., Marcovina, S. M. & Brewer, H. B., Jr.: Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA 93: 11448-11453, 1996.
15. Hoeg, J. M., Santamarina-Fojo, S., Vaisman, B. L., Hoyt, R. F., Jr., Feldman, S., Cornhill, F., Herderick, E., Talley, G., Wood, D., Marcovina, S. & Brewer, H. B., Jr.: Lecithin-cholesterol acyltransferase transgenic rabbits: Hyperalphalipoproteinemia and diet-induced atherosclerosis. Circulation 92: I, 359, 1995.
16. Hoeg, J. M., Vaisman, B. L., Demosky, S. J. J., Meyn, S. M., Talley, G. D., Hoyt, R. F., Jr., Feldman, S., Bérard, A. M., Sakai, N., Wood, D., Brousseau, M. E., Marcovina, S., Brewer, H. B., Jr. & Santamarina-Fojo, S.: Lecithin: cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 277: 4396-4402, 1996.
17. Koizumi, J., Inazu, A., Yagi, K., Koizwni, I., Uno, Y., Kajinami, K., Miyamoto, S., Moulin, P., Tall, A. R., Mabuchi, H. & Takeda, R.: Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis 90: 189-196, 1991.
18. LeBoeuf, R. C., Doolittle, M. H., Montcalm, A., Martin, D. C., Reue, K. & Lusis, A. J.: Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. J. Lipid Res. 31: 91-101, 1990.
19. Levine, J. B. & Zak, B.: Automated determination of serum total cholesterol. Clin. Chim. Acta 10: 381-384, 1964.
20. Li, H., Reddick, R. L. & Maeda, N.: Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler. Thromb. 13: 1814-1821, 1993.
21. Liu, A. C., Lawn, R. M., Verstuyft, J. G. & Rubin, E. M.: Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J. Lipid Res. 35: 2263-2267. 1994.
22. Marotti, K. R., Castle, C. K., Boyle, T. P., Lin, A. H., Murray, R. W. & Melchior, G. W.: Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364: 73-75, 1993.
23. Marotti, K. R., Castle, C. K., Murray, R. W., Rehberg, E. F., Polites, H. G. & Melchior, G. W.: The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insight from studies with transgenic mice. Arterioscler. Thromb. 12: 736-744, 1992.
24. Mehlum, A. & Prydz, H.: Mice transgenic for the human LCAT gene. Clin. Genet. 46: 92, 1994.
25. Mehlum, A., Staels, B., Duverger, N., Tailleux, A., Castro, G., Fievet, C., Luc, G., Fruchart, J.-C., Olivecrona, G., Skretting, G., Auwerx, J. & Prydz, H.: Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile. Eur. J. Biochem. 230: 567-575, 1995.
26. Paigen, B., Morrow, A., Holmes, P. A., Mitchell, D. & Williams, R.: Quantitative assessment of atherosclerotic lesion in mice. Atherosclerosis 68: 231-240, 1987.
27. Pászty, C., Maeda, N., Verstuyft, J. & Rubin, E.M.: Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903, 1994.
28. Plump, A. S., Scott, C. J. & Breslow, J. L.: Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 91: 9607-9611, 1994.
29. Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G. & Clift, S. M.: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353: 265-267, 1991.
30. Skrede, S. & Björkhem, J.: Synthesis of cholestanol from intestinal 7α-hydroxy-4-cholesten-3-one. J. Biol. Chem. 257: 8363-8367, 1982.
31. Subbaiah, P. V., Liu, M., Bolan, P. J. & Paltauf. F.: Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters. Biochim. Biophys. Acta 1128: 83-92, 1992.
32. Subbaiah, P. V., Liu, M. & Paltauf, F.: Role of sn-2 acyl group of phosphatidylcholine in determining the positional specificity of lecithin: cholesterol acyltransferase. Biochemistry 33: 13259-13266, 1994.
33. Takayama, M., Itoh, S., Nagasaki, T. & Tanimizu, I.: A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta 79: 93-98, 1977.
34. Tall, A. R.: Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J. Int. Med. 237: 5-12, 1995.
35. Vaisman, B., Klein, H.-G., Rouis, M., Bérard, A. M., Kindt, M. R., Talley, G., Meyn, S. M., Hoyt, R. F., Marcovina, S. M., Albers, J. J., Hoeg, J. M., Brewer, B., Jr. & Santamarina-Fojo, S.: Overexpression of human lecithin: cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275, 1995.
36. Wybenga, D. R. & Inkpen, J. A.: Lipids. In: Henry, R. J. (Ed.): Clinical Chemistry. Principles and Technics. Harper & Row, New York, San Francisco and London 1974, pp. 1421ff.
37. Yen, F. T., Deckelbaum, R. J., Mann, C. J., Marcel, Y. L. Milne, R. W. & Tall, A. R.: Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J. Clin. Invest. 83: 2018-2024, 1989.